A recent study demonstrated that treatment of SH-SY5Y neuroblastoma cells with Aβ(25−35) activates the IRE1–XBP1 pathway, enhancing interactions with key MAM proteins such as IP3R, GRP75, and VDAC1. This evidence concerns the gene XBP1 and neuroblastoma.